Hinde El Otmani/ISTH
Oct 16, 2025, 04:37
Hinde El Otmani’s Team Explores Plasmin-Mediated Proteolysis of von Willebrand Factor in Acutely Ill Patients
RPTH Journal shared on LinkedIn:
”Elevated von Willebrand factor (VWF) is common in liver disease, but its regulation remains unclear.
The latest study from Hinde El Otmani explores how plasmin-mediated VWF cleavage may lead to microvascular changes in acutely ill patients.
Check it out here.
Co-authors: Ton Lisman, Coen Maas, Marilena Stamouli, Jelle Adelmeijer”
Read the full article in RPTH.
Article: Plasmin-mediated proteolysis of von Willebrand factor in patients with acute and chronic liver disease
Authors: Hinde El Otmani, Marilena Stamouli, Jelle Adelmeijer, William Bernal, Coen Maas, Vishal C. Patel, Ton Lisman
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Mar 10, 2026, 12:48Kayley Pappas: Stroke Care is Evolving and Mayo Clinic Is Helping Lead The Way
-
Mar 10, 2026, 12:47Jimmy Lowery: The Clinical and Financial Responsibilities of Blood Bank Inventory
-
Mar 10, 2026, 12:41Heghine KhachatryanÖ‰ Age-Adjusted D-Dimer Thresholds for Safer and Smarter VTE Rule-Out
-
Mar 10, 2026, 12:39Roberta Gualtierotti: How Do Sex and Gender Influence VTE in Patients with Cancer?
-
Mar 10, 2026, 12:39Tareq Abadl: Detecting the Hidden Risk of NAIT in the Lab
-
Mar 10, 2026, 12:36Amitabh Kulkarni: What Parents Need to Know About Iron Deficiency Anemia in Children
-
Mar 10, 2026, 12:23Bastu Odoka: The Laboratory’s Role in Preventing RhD Disease
-
Mar 10, 2026, 12:22Kalyan Roy: Rediscovering Cold-Stored Platelets in Modern Transfusion Medicine
-
Mar 10, 2026, 04:15Abdul Mannan: NK Cell ALL and the Diagnostic Challenge of a Provisional Entity: